My research interests focus on the roles mitochondria play in aspects of eukaryotic life, ranging from their origin, metabolism, biogenesis and role they play in cell death pathways. These are interrogated using biochemical, molecular biology, genetic and cell biology techniques. I incorporate these interests into classes I teach to provide an understanding of practical techniques and also the current literature in the field. I studied biochemistry at the University of Leeds, with an industrial placement at Astra Charnwood, followed by a PhD at the University of Bristol, supervised by Professor Andrew Halestrap, to characterise the molecular composition of the mitochondrial permeability transition pore, with support from MitoKor. My post-doctoral training on the mitochondrial pathway of apoptosis supervised by Dr Doug Green was at the La Jolla Institute of Allergy and Immunology in San Diego, California and St Jude Children's Research Hospital in Memphis, Tennessee. I then was an associate research scientist working in the laboratory of Professor Alexander Tzagoloff at Columbia University in New York to study biogenesis of mitochondrial cytochrome c oxidase in budding yeast, Saccharomyces cerevisiae. I held independent positions as assistant professor at the New York Institute of Technology in New York and Staffordshire University in Stoke-on-Trent where I continued my research and taught subjects related to biochemistry, cell biology, genetics and molecular biology. I am now a senior lecturer in biotechnology at Liverpool John Moores University.  I am a strong supporter of scientific communications and outreach to disseminate scientific developments and knowledge to a broader audience with the goal of increasing the general support of the scientific process. I also direct Biomed News, a free biomedical research literature discovery platform that uses machine learning.

Guilherme G. Moreira is a PhD Student at Protein Misfolding and Amyloids in Biomedicine (PMAB) group (http://folding.fc.ul.pt) at Faculty of Sciences of the University of Lisbon and affiliated to BioISI Biosystems & Integrative Sciences Institute. Born in 1995, has graduated in Biochemistry (2016) and completed his master's in Medical Biochemistry (2018) at the University of Lisbon. Guilherme started his PhD studies with an FCT PhD Studentship on the PMAB GomesLab (2021) with the project entitled The calcium-binding protein S100B as a novel chaperone preventing Tau aggregation in Alzheimer's disease. Guilherme is the first author of 3 published peer-reviewed international papers (2019, 2021 and 2023), co-author of 1 published book chapter (2020) and co-author of 2 published peer-reviewed international paper (2021 and 2022), as well as author of 19 posters and 5 oral communications presented in national and international events. Has been awarded 6 travel/accommodation and registration awards for international meetings. Research Identifiers Google Scholar: https://scholar.google.com/citations?user=https://scholar.google.com/citations?user=BTcYDiYAAAAJ&hl=pt-PT&user=BTcYDiYAAAAJ Scopus: https://www.scopus.com/authid/detail.uri?authorId=57212030809 ORCID: https://orcid.org/0000-0003-4791-5403 Web Of Science: https://www.webofscience.com/wos/author/record/B-6154-2018

I obtained my PhD in plant molecular biology from the University of Nottingham and have spent the past 30 years in science publishing. I've worked for various journals, including Nature and Trends in Biochemical Sciences, and also edited many books. I was the Executive Editor of FEBS Open Bio from its launch in 2011 until 2019.

Nanotechnology, drug delivery systems, biosensors, chromatography, advanced materials characterization

Dr. Isabel Varela-Nieto graduated and earned her doctorate in Chemistry, Biochemistry Section, at the University Complutense of Madrid (Spain). She has been a visiting guest scientist at the Medical Schools of Uppsala (FEBS Fellow, Sweden) and San Diego (MEC Sabbatical, USA). She is Professor of Research at the CSIC and group leader at the CIBER of rare diseases (CIBERER, ISCIII) in Madrid. From the early 1990s she has been studying hearing neurobiology and IGF-1 actions. She was the first Chair of the SEBBM Science for Society working group with which she actively collaborates, and member of the FEBS Network working group. She is currently the president of the SEBBM, a member of the FEBS Science and Society Committee and of the ISC Finances Committee.

The FEBS Journal is an international journal devoted to the rapid publication of full-length papers covering a wide range of topics in any area of the molecular life sciences.